138 related articles for article (PubMed ID: 16213703)
1. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors.
Xia SJ; Barr FG
Eur J Cancer; 2005 Nov; 41(16):2513-27. PubMed ID: 16213703
[TBL] [Abstract][Full Text] [Related]
2. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
[TBL] [Abstract][Full Text] [Related]
3. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
Schwarzbach MH; Koesters R; Germann A; Mechtersheimer G; Geisbill J; Winkler S; Niedergethmann M; Ridder R; Buechler MW; von Knebel Doeberitz M; Willeke F
Oncogene; 2004 Sep; 23(40):6798-805. PubMed ID: 15286712
[TBL] [Abstract][Full Text] [Related]
4. Fusion genes in solid tumors.
Aman P
Semin Cancer Biol; 1999 Aug; 9(4):303-18. PubMed ID: 10448117
[TBL] [Abstract][Full Text] [Related]
5. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.
Riggi N; Cironi L; Suvà ML; Stamenkovic I
J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072
[TBL] [Abstract][Full Text] [Related]
6. TLS, EWS and TAF15: a model for transcriptional integration of gene expression.
Law WJ; Cann KL; Hicks GG
Brief Funct Genomic Proteomic; 2006 Mar; 5(1):8-14. PubMed ID: 16769671
[TBL] [Abstract][Full Text] [Related]
7. Fusion oncogenes and tumor type specificity--insights from salivary gland tumors.
Stenman G
Semin Cancer Biol; 2005 Jun; 15(3):224-35. PubMed ID: 15826837
[TBL] [Abstract][Full Text] [Related]
8. Transcription factors in human leukaemias.
Cleary ML
Cancer Surv; 1992; 15():89-104. PubMed ID: 1451116
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal translocations in sarcomas: prospects for therapy.
Tomescu O; Barr FG
Trends Mol Med; 2001 Dec; 7(12):554-9. PubMed ID: 11733218
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas.
Dela Cruz F; Matushansky I
Discov Med; 2011 Oct; 12(65):307-17. PubMed ID: 22031668
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal translocation master genes, mouse models and experimental therapeutics.
Rabbitts TH
Oncogene; 2001 Sep; 20(40):5763-77. PubMed ID: 11607826
[TBL] [Abstract][Full Text] [Related]
12. Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.
Maire G; Brown CW; Bayani J; Pereira C; Gravel DH; Bell JC; Zielenska M; Squire JA
Cancer Genet Cytogenet; 2008 Mar; 181(2):81-92. PubMed ID: 18295659
[TBL] [Abstract][Full Text] [Related]
13. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
14. Expression of DOL54 is not restricted to myxoid liposarcomas with the FUS-DDIT3 chimera but is found in various sarcomas.
Panagopoulos I; Mertens F; Isaksson M; Mandahl N
Oncol Rep; 2004 Jul; 12(1):107-10. PubMed ID: 15201968
[TBL] [Abstract][Full Text] [Related]
15. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma.
Szuhai K; IJszenga M; Tanke HJ; Taminiau AH; de Schepper A; van Duinen SG; Rosenberg C; Hogendoorn PC
Cancer Genet Cytogenet; 2007 Jan; 172(1):12-22. PubMed ID: 17175374
[TBL] [Abstract][Full Text] [Related]
16. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?
Charytonowicz E; Cordon-Cardo C; Matushansky I; Ziman M
Cancer Lett; 2009 Jul; 279(2):126-36. PubMed ID: 19008039
[TBL] [Abstract][Full Text] [Related]
17. Perspective: chromosomal translocations can affect genes controlling gene expression and differentiation--why are these functions targeted?
Rabbitts TH
J Pathol; 1999 Jan; 187(1):39-42. PubMed ID: 10341705
[TBL] [Abstract][Full Text] [Related]
18. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of lymphocyte proliferation by chromosomal translocations and sequential genetic changes.
Klein G
Bioessays; 2000 May; 22(5):414-22. PubMed ID: 10797481
[TBL] [Abstract][Full Text] [Related]
20. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes.
Oliveira AM; Perez-Atayde AR; Dal Cin P; Gebhardt MC; Chen CJ; Neff JR; Demetri GD; Rosenberg AE; Bridge JA; Fletcher JA
Oncogene; 2005 May; 24(21):3419-26. PubMed ID: 15735689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
